Literature DB >> 1636229

Cytologic and histologic features of superficial bladder cancer.

J Y Ro1, G A Staerkel, A G Ayala.   

Abstract

Despite technologic advances in diagnostic skills, cytologic and histologic evaluation is still the standard for the identification of bladder cancer, and these two techniques are critical in therapy selection and post-treatment surveillance. The key to the proper interpretation of cytologic specimens lies in appropriate collection and handling of the sample. Because treatment differs according to the histologic type of a tumor, when a mixture of types is found, all should be listed with their relative proportions. Both pathologists and urologists must be aware of the importance of the muscularis mucosae; a transitional-cell carcinoma may invade this layer without extending into the true muscle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636229

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  33 in total

1.  Clinical correlation between serum YKL-40 protein level and recurrence of non-muscle invasive bladder cancer.

Authors:  Jiasheng Yan; Peijun Shen; Junhua Zheng; Min Liu
Journal:  Ann Transl Med       Date:  2015-12

2.  Correlation of nuclear p53 over-expression with clinical and histopathological features of transitional cell bladder cancer.

Authors:  Z Sinik; T Alkibay; O Ataoğlu; G Akyol; H Tokuçoğlu; I Bozkirli
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

3.  Cellular morphological parameters of the human urinary bladder (malignant and normal).

Authors:  Ahmad Keshtkar; Asghar Keshtkar; Pat Lawford
Journal:  Int J Exp Pathol       Date:  2007-06       Impact factor: 1.925

4.  Low-Grade, Multiple, Ta Non-muscle-Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression.

Authors:  R B Nerli; Shridhar C Ghagane; K Shankar; Adarsh C Sanikop; Murigendra B Hiremath; Neeraj S Dixit; Laxman Magadum
Journal:  Indian J Surg Oncol       Date:  2018-01-29

5.  Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.

Authors:  Patrick J Hensley; Daniel Zetter; Craig M Horbinski; Stephen E Strup; Natasha Kyprianou
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

6.  Improved prognosis assessment for patients with bladder carcinoma.

Authors:  T Otto; A Bex; U Schmidt; A Raz; H Rübben
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  Repeated transurethral resection for non-muscle invasive bladder cancer.

Authors:  Ming Cao; Guoliang Yang; Jiahua Pan; Jie Sun; Qi Chen; Yonghui Chen; Haige Chen; Wei Xue
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 8.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.

Authors:  Marc Birkhahn; Anirban P Mitra; Anthony J Williams; Gitte Lam; Wei Ye; Ram H Datar; Marija Balic; Susan Groshen; Kenneth E Steven; Richard J Cote
Journal:  Eur Urol       Date:  2009-09-09       Impact factor: 20.096

10.  AgNOR/P53 expression compared with different grades in bladder carcinoma.

Authors:  M Karakök; A Aydin; K Bakir; R Uçak; C Korkmaz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.